Dx-Sys, Inc.

897 Independence Ave
Suite 4E
Mountain View,  CA  94043

United States
  • Booth: 1356


Dx-Sys has developed an ultra-sensitive lateral flow Point of Care Test for brain biomarker (GFAP) at sub-pico gram levels using lanthanide chemistry. Results are obtained in <1 hr in a Time Resolved Fluorescence Reader. We offer stabilization buffers for HRP conjugated antibodies and drugs. Dx-Sys services are custom mono and polyclonal antibodies, recombinant protein expression, immunoassay development, contract manufacturing of ELISA and Lateral flow assay kits and pre-clinical formulations.

 Press Releases

  • Dx-Sys Inc. (Booth # 1356) has developed an ultra-sensitive, Lateral Flow Point of Care diagnostic test for Glial Fibrillary Acidic Protein (GFAP), a potential biomarker for Traumatic Brain Injury (TBI).  The test is a one-step quantitative immunochromatographic assay which can be performed in 60 minutes using a Time Resolved Fluorescence Strip Reader with a sensitivity of < 1 pg/mL of GFAP in human serum. The POCT can also be performed on a Qiagen’s standard Fluorescence strip reader for Europium chelates with a sensitivity of 10 pg/mL for GFAP.

 Additional Info

Included in the Export Interest Directory?
Business Needs:
Direct Sales, Distributor/Agent/Representative, Investor, Joint Ventures, Licensing Agreements